The RMA has defined hormone replacement therapy as the administration of oestrogen preparations often in combination with progesterone to offset a hormone deficiency following surgically induced or naturally occurring menopause.
Treatment can be in the form of tablets or patches, and must be prescribed by a doctor. Such medications can consist of:
37204 there is some evidence that hormone replacement therapy may be a factor in the development of the condition under consideration, a cerebrovascular accident.
1169 the veteran is a woman.
37202 the veteran was postmenopausal at the time of the clinical onset of cerebrovascular accident.
36719 the veteran has had hormone replacement therapy at some time.
37206 the veteran had hormone replacement therapy for treatment of an illness or injury which is identifiable.
37205 for treatment of the identified illness or injury, the veteran had hormone replacement therapy for a period of at least the 21 days before the clinical onset of the condition under consideration, a cerebrovascular accident.
37207 the veteran has established the causal connection between hormone replacement therapy and VEA service for the clinical onset of cerebrovascular accident.
37208 the veteran has established the causal connection between hormone replacement therapy and operational service for the clinical onset of cerebrovascular accident.
or
37209 the veteran has established the causal connection between hormone replacement therapy and eligible service for the clinical onset of cerebrovascular accident.
37210 the identified illness or injury for which the veteran had hormone replacement therapy is causally related to operational service.
37211 the identified illness or injury for which the veteran had hormone replacement therapy is causally related to eligible service.